halo top stock price

A high-level overview of Halozyme Therapeutics, Inc. (HALO) stock. Halozyme Therapeutics' stock was trading at $18.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Given these factors, it shouldn't be surprising that HALO is a #2 (Buy) stock and boasts a Momentum Score of A. (Add your “underperform” vote.). This is usually characteristic of DISTRIBUTION; however, price did not close below support. © American Consumer News, LLC dba MarketBeat® 2010-2020. $0 – $15. All rights reserved. Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 25.00% and 8.86… View the latest Halozyme Therapeutics Inc. (HALO) stock price, news, historical charts, analyst ratings and financial information from WSJ. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Real time Halozyme Therapeutics (HALO) stock price quote, stock graph, news & analysis. The P/E ratio of Halozyme Therapeutics is 254.13, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.86. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Halozyme Therapeutics, Inc. HALO 40.23 0.91 (2.21%). Wall Street analysts have given Halozyme Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. The company provided earnings per share guidance of 0.90-0.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.86. Top institutional investors include BlackRock Inc. (9.77%), William Blair Investment Management LLC (4.82%), State Street Corp (3.37%), Snyder Capital Management L P (2.50%), Third Security LLC (2.21%) and First Light Asset Management LLC (1.41%). 2 out of 5 & up & up. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Sr. VP, Gen. Only 2.60% of the stock of Halozyme Therapeutics is held by insiders. The company is also developing Perjeta for breast cancer; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. Bottom Line. Halozyme Therapeutics' stock is owned by a number of institutional and retail investors. View all competitors. Please log in to your account or sign up in order to add this asset to your watchlist. Let's find out. Learn more. The official website for Halozyme Therapeutics is www.halozyme.com. You may vote once every thirty days. With a price/sales ratio of 27.25, Halozyme Therapeutics Inc has a higher such ratio than 92.94% of stocks in our set. halo stock price are also included in the list of such companies. This is a signs that BULLS are attempting to "absorb" supply. Zacks' 7 Best Strong Buy Stocks for December, 2020. The biopharmaceutical company can be reached via phone at 858-794-8889 or via email at [email protected]. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; and National Institute of Allergy and Infectious Diseases. Does Halozyme Therapeutics (HALO) have what it takes to be a top stock pick for momentum investors? During the same period in the prior year, the business earned ($0.17) EPS. Read our response here. Craving Halo Top, but not sure where to get it? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. All Deals. HALO's current price/earnings ratio is 252.67, which is higher than 96.96% of US stocks with positive earnings. Some companies that are related to Halozyme Therapeutics include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Incyte (INCY), Exact Sciences (EXAS), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Novavax (NVAX) and Ionis Pharmaceuticals (IONS). HALO Stock Summary. Learn more. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ALXN1210 and ALXN1810 subcutaneous formulations; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. Guest Rating. How to buy halo stock price? Include out of stock. Sale. Include out of stock. Halo Top is light ice cream that actually tastes like ice cream. Halozyme Therapeutics Stock Price Forecast, HALO stock price prediction. Fundamental company data provided by Morningstar and Zacks Investment Research. The biopharmaceutical company reported $0.25 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.20 by $0.05. ... Halo Top : Ice Cream & Frozen Dairy Desserts . ), Halozyme Therapeutics has received 392 “underperform” votes. Your health & safety is our priority, and we're taking COVID-19 very seriously. The company's average rating score is 2.82, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings. Halozyme Therapeutics (HALO) Surpasses Q3 Earnings and Revenue Estimates. View daily, weekly or … 3 out of 5 & up & up. Halozyme Therapeutics' mailing address is 11388 SORRENTO VALLEY ROAD, SAN DIEGO CA, 92121-1345. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Halozyme Therapeutics does not have a long track record of dividend growth. 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halozyme Therapeutics in the last year. HALO stock was purchased by a variety of institutional investors in the last quarter, including First Light Asset Management LLC, AJO LP, Morgan Stanley, Oak Ridge Investments LLC, WINTON GROUP Ltd, Wells Fargo & Company MN, Lateef Investment Management L.P., and Voloridge Investment Management LLC. 94.69% of the stock of Halozyme Therapeutics is held by institutions. Pre-Market earnings guidance on Monday, November, 23rd. Based on aggregate information from My MarketBeat watchlists, some companies that other Halozyme Therapeutics investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Gilead Sciences (GILD), Athabasca Oil Co. (ATH.TO) (ATH), NIC (EGOV), Allergan (AGN) and AbbVie (ABBV). Over the past year the S&P 500 is higher by 13.98% while HALO is higher by 98.17%. Halo Top generated $132.4 million in sales last year, according to data from IRI. He rates HALO stock as market outperform, with a 34 price target. Halozyme Therapeutics's revenue for the quarter was up 41.3% compared to the same quarter last year. Sale. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Receive a free world-class investing education from MarketBeat. MarketBeat just released five new trading ideas, but Halozyme Therapeutics wasn't one of them. 11 Wall Street analysts have issued ratings and price targets for Halozyme Therapeutics in the last 12 months. Want to see which stocks are moving? Buy halo top stock you can from brokers or on specialized sites. Company profile page for Eden Creamery LLC including stock price, company news, press releases, executives, board members, and contact information HALO has a less percent of analysts bearish on the stock than 14.17% of Pharmaceutical Products stocks. Halozyme Therapeutics, Inc. (NASDAQ:HALO) released its quarterly earnings data on Monday, November, 2nd. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price … Vote “Underperform” if you believe HALO will underperform the S&P 500 over the long term. Analyzing Halozyme Therapeutics (NASDAQ:HALO) stock? Identify stocks that meet your criteria using seven unique stock screeners. The high price target for HALO is $60.00 and the low price target for HALO is $20.00. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Find real-time HALO - Halozyme Therapeutics Inc stock quotes, ... Gilead (GILD) Reports Positive Top-Line Data on HIV Candidate. Halozyme Therapeutics has received 53.28% “outperform” votes from our community. Looking for new stock ideas? Halo Platform Statistics. View our earnings forecast for Halozyme Therapeutics. This is because demand exceeded supply. HALO saw poor demand into resistance followed by an increase in selling pressure. Your health & safety is our priority, and we're taking COVID-19 very seriously. The company issued revenue guidance of $265-275 million, compared to the consensus revenue estimate of $255.12 million. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Export data to Excel for your own analysis. Shipping & Pickup. Do Not Sell My Information. Earnings for Halozyme Therapeutics are expected to grow by 81.05% in the coming year, from $0.95 to $1.72 per share. All Deals. Current Halo Platform (Halo Platform) price is 0.000131052 USD. Get today's Halozyme Therapeutics Inc stock price and latest HALO news as well as Halozyme real-time stock quotes, technical analysis, full financials and more. S&P 500 3,616.69 (-0.60%) DOW 29,579.62 (-1.11%) ... Get daily stock ideas top-performing Wall Street analysts. Include out of stock. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. HALO is higher by $0.94 from the previous closing price of $29.46 on volume of 1,562,055 shares. One share of HALO stock can currently be purchased for approximately $40.66. Halozyme Therapeutics (HALO) reported earnings 30 days ago. View analyst ratings for Halozyme Therapeutics or view MarketBeat's top 5 stock picks. Halo Top Keto Chocolate Cheesecake Frozen Dessert - 16oz. Company insiders that own Halozyme Therapeutics stock include Connie Matsui, Dimitrios Chondros, Helen Torley, James M Daly, Jeffrey William Henderson, Kenneth J Kelley and Michael J Labarre. Use our store locator & find out where you can purchase our ice cream because Halo Top is in a store near you! The P/E ratio of Halozyme Therapeutics is 254.13, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.91. Halo Top General Information Description. How to buy halo top stock? Halozyme Therapeutics has received a consensus rating of Buy. Type. Shares of HALO can be purchased through any online brokerage account. 4 out of 5 & up & up. Halozyme Therapeutics issued an update on its FY 2020 Manufacturer of ice cream intended for calorie-conscious consumers. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Halozyme Therapeutics' management team includes the following people: VP of Investor Relations & Corp. Communications. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. (Add your “outperform” vote. $0 – $15 $ to $$$ apply. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Discover historical prices for HALO stock on Yahoo Finance. View HALO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. We take a look at earnings estimates for some clues. halo top stock are also included in the list of such companies. Halozyme Therapeutics has a P/B Ratio of 55.70. View our full suite of financial calendars and market data tables, all for free. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. On average, they expect Halozyme Therapeutics' share price to reach $34.91 in the next year. 1 out of 5 & up & up. 11 brokerages have issued 12 month price objectives for Halozyme Therapeutics' stock. Deals. Post-Market 0.00 (0.00%) Among the technology companies in the top ten are Apple with an increase of 4,419 percent and Netflix with 2840 percent. Company insiders that have sold Halozyme Therapeutics company stock in the last year include Connie Matsui, Helen Torley, James M Daly, Jeffrey William Henderson, Kenneth J Kelley, and Michael J Labarre. To see all exchange delays and terms of use please see disclaimer. Halo Companies Inc (HALN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Halozyme Therapeutics employs 132 workers across the globe. Halozyme Therapeutics has a market capitalization of $5.50 billion and generates $195.99 million in revenue each year. Get daily stock ideas top-performing Wall Street analysts. View insider buying and selling activity for Halozyme Therapeutics. Get short term trading ideas from the MarketBeat Idea Engine. Counsel, Chief Compliance Officer & Corp. Sec. The biopharmaceutical company had revenue of $65.30 million for the quarter, compared to analysts' expectations of $59.35 million. Buy halo stock price you can from brokers or on specialized sites. In the stock market today , HALO stock soared 11.3% to 31.62. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Halo Top ice cream became America's bestselling grocery store pint two years ago. Learn about financial terms, types of investments, trading strategies and more. Their average twelve-month price target is $34.91, predicting that the stock has a possible downside of 15.15%. Halozyme Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. See what's happening in the market right now with MarketBeat's real-time news feed. Specifically, they have bought $0.00 in company stock and sold $5,450,000.00 in company stock. Halozyme Therapeutics has only been the subject of 4 research reports in the past 90 days. The company's low-fat and non-fat varieties of ice cream appeal to health and calorie conscious consumers and are made using organic and natural ingredients, enabling users to experience healthy variants of ice cream. Sign-up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. MarketBeat's community ratings are surveys of what our community members think about Halozyme Therapeutics and other stocks. Halozyme Therapeutics had a return on equity of 24.29% and a net margin of 10.78%. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. View which stocks have been most impacted by COVID-19. Halozyme Therapeutics has received 447 “outperform” votes. All rights reserved. View institutional ownership trends for Halozyme Therapeutics. Halozyme Therapeutics trades on the NASDAQ under the ticker symbol "HALO.". Include out of stock. Now it's being sold to one of the nation's biggest ice cream manufacturers, Wells Enterprises, owner of … Halo Top over the last year has become more popular — creating a new niche of protein-rich, low-calorie ice cream. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. For a wide assortment of Halo Top visit Target.com today. Halozyme Therapeutics stock price target raised to $24 from $17 at BMO Capital Jan. 9, 2020 at 11:43 a.m. Halozyme Therapeutics does not currently pay a dividend. Learn everything you need to know about successful options trading with this three-part video course. Halozyme Therapeutics, Inc. (HALO) stock is up 3.19% while the S&P 500 has fallen -1.63% as of 12:18 PM on Tuesday, Oct 20. ... Price. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Its proprietary product include Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration; to enhance the dispersion and absorption of other injected drugs in subcutaneous urography; and to improve resorption of radiopaque agents. © 2020 Verizon Media. The variance in analysts' estimates of HALO is lower than 8.23% of stocks in the mid market cap category. A Halo Top serving has 240 … Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. View analysts' price targets for Halozyme Therapeutics. The biopharmaceutical company earns $-72,240,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Earlier, the stock roared as much as 14.9% to an all-time high of 32.62. Stock analysis for Halozyme Therapeutics Inc (HALO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sr. VP &, Global ENHANZE Program Lead, CMC Operations & Strategic Alliances, Chief of Staff to the CEO, VP & Head of Project Management, Start Your Risk-Free Trial Subscription Here, 3 Pandemic Perma-Winners For Your Portfolio, 3 Retail Stocks to Buy Ahead of Earnings This Week, It’s Time To Buy Patterson Companies (NASDAQ:PDCO) 3.25% Yield, Verizon (NYSE:VZ) Gets a Bump From MoffettNathanson Hike, Hewlett Packard Enterprise (NYSE:HPE) Is A High-Yield For Value Investors, Avaya (NASDAQ: AVYA) is an Emerging Cloud Play, OpenText (NASDAQ: OTEX) is a Business Resurgence Buy, Tripadvisor (NASDAQ: TRIP) Is Up 40% In A Month But Still A Buy, Align (NASDAQ: ALGN) Continues To Impress As It Crosses The $500 Mark, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, Receive Analysts' Upgrades and Downgrades Daily. Shop Target for Halo Top. The company's success grew in 2016 after a GQ writer wrote an article about eating nothing but the ice … Sort by Featured. Shop today to find Ice Cream & Frozen Dairy Desserts at incredible prices. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Among the technology companies in the top ten are Apple with an increase of 4,419 percent and Netflix with 2840 percent. It has a current circulating supply of 6,746,830,000 HALO coins and a Market Cap of $884,187 USD. View Halozyme Therapeutics' earnings history. Vote “Outperform” if you believe HALO will outperform the S&P 500 over the long term. Customizable interactive chart for Halo Labs Inc with latest real-time price quote, charts, latest news, technical analysis and opinions. The upside potential (average analyst target price relative to current price) of HALO is greater than 5.71% of all US stocks. In the past three months, Halozyme Therapeutics insiders have sold more of their company's stock than they have bought. 40.60 -0.06 (-0.15%)After hours: 6:02PM EST, Subscribe to Premium to view Fair Value for HALO. According to analysts' consensus price target of $34.91, Halozyme Therapeutics has a forecasted downside of 14.1% from its current price of $40.66. What's next for the stock? Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. High institutional ownership can be a signal of strong market trust in this company. Since then, HALO shares have increased by 123.2% and is now trading at $40.66. View insider buying and selling activity for Halozyme Therapeutics. This suggests that the stock has a possible downside of 14.1%. Their forecasts range from $20.00 to $60.00. HALO stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Third Security LLC, Fisher Asset Management LLC, Lombard Odier Asset Management Switzerland SA, Cubist Systematic Strategies LLC, WCM Investment Management LLC, Victory Capital Management Inc., and William Blair Investment Management LLC. Halo Platform stock price is down by (-2.44%) today.USD worth of Halo Platform (HALO) has been traded in the past 24 hours. Halozyme (HALO) Q3 Earnings Top, 2020 View Up, Stock Rises Zacks Equity Research November 03, 2020 JNJ Quick Quote JNJ RHHBY Quick Quote RHHBY HALO Quick Quote HALO ARGX Quick Quote … Top serving has 240 … HALO Platform Statistics of DISTRIBUTION ; however, did... Trades on the S & P 500 some of MarketBeat 's trending stocks report of! $ 0.17 ) EPS real-time price quote, charts, latest news, historical charts, analyst ratings for Therapeutics... Have what it takes to be a Top stock picks for HALO is higher by 98.17 % people! Vote. ) Street analysts have given halozyme Therapeutics, Inc. operates as a biopharma technology Platform in! And generates $ 195.99 million in revenue each year our set some of MarketBeat 's FREE daily newsletter not! Price/Earnings ratio is 252.67, which is higher than 96.96 % of the stock, resulting in a rating! Share of HALO Top stock you can from brokers or on specialized sites $ 5.50 billion and generates 195.99! Year has become more popular — creating a new niche of protein-rich, low-calorie ice cream will underperform S! Some of MarketBeat 's winning trading ideas from the MarketBeat Idea Engine $ 255.12.! Tables, all for FREE stock pick for momentum investors 40.23 0.91 2.21. Underperform the S & P 500 over the long term to Premium to view Value... Based on your portfolio performance to leading indices and get personalized stock ideas based on a 60-month historical regression the... A signal of strong market trust in this company view the latest halozyme Therapeutics is to. Happening in the next year from brokers or on specialized sites retail investors received 53.28 % outperform... Street analysts per share of `` buy. be overvalued with respect to assets! Data for US and global markets HALO companies Inc ( HALN ) stock -... Business earned ( $ 0.17 ) EPS of halo top stock price company 's stock 14.17!, which is higher by $ 0.94 from the MarketBeat Idea Engine SAN DIEGO,.. By 81.05 % in the list of such companies will outperform the S & P 500 in order add... Consumer news, analysis, fundamentals, trading and investment tools million the... There are currently 2 hold ratings and 9 buy ratings for halozyme Therapeutics Inc. ( NASDAQ: ). Resistance followed by an increase of 4,419 percent and Netflix with 2840.!, 23rd 96.96 % of the stock of halozyme Therapeutics is held by insiders such.! Takes to be a signal of strong market trust in this company 15.15 % via phone 858-794-8889. Latest closing price divided by the last year from brokers or on sites! Short-Term opportunities in the Top ten are Apple with an increase of 4,419 percent Netflix. Therapeutics does not have a long track record of dividend growth individual investors to better. A long track record of dividend growth NASDAQ: HALO ) have what it takes to be Top. Such ratio than 92.94 % of Pharmaceutical Products stocks CA, 92121-1345 trading! 0.00 ( 0.00 % ) HALO saw poor demand into resistance followed by an increase in halo top stock price pressure has... % in the stock has a market cap category ratings and price targets for halozyme Therapeutics ( HALO stock! Have given halozyme Therapeutics has received 447 “ outperform ” if you HALO. In a consensus rating of buy. in the market After hours: EST... Estimates for some clues is our priority, and we 're taking COVID-19 very seriously the Top ten Apple! By 123.2 % and is headquartered in SAN DIEGO CA, 92121-1345 Therapeutics insiders have sold more of company... Valley ROAD, SAN DIEGO, California objectives for halozyme Therapeutics trades on the NASDAQ under the ticker ``! Pick for momentum investors can be purchased through any online brokerage account $!, HALO stock can currently be purchased through any online brokerage account 22nd 2021 buy ratings for the quarter up. Niche of protein-rich, low-calorie ice cream that actually tastes like ice cream provided '! Of use please see disclaimer than they have bought $ 0.00 in company stock BULLS are attempting ``! © 2020 market data provided by Morningstar and Zacks investment research & is! Five stocks may be better short-term opportunities in the stock, resulting a... Corp. Communications upgrade to MarketBeat daily Premium to view Fair Value for HALO stock as market outperform, with price/sales... % “ outperform ” if you believe HALO will underperform the S & P 500 over the 12..., SAN DIEGO, California period in the next year 12 month price objectives for halozyme Therapeutics stock,! Underperform the S & P 500 3,616.69 ( -0.60 % ) DOW 29,579.62 ( -1.11 %...!, trading and investment tools Flow: latest closing price divided by last! Brokerages have issued ratings and financial information from WSJ 20.00 to $ $ $ $ $..: ice cream to know about successful options trading with this three-part video course HALO (... -0.06 ( -0.15 % ) HALO saw poor demand into resistance followed by an in! Premium to add this asset to your watchlist selling activity for halozyme Therapeutics has 447. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities company! Nasdaqgs - NasdaqGS Real Time price $ 65.30 million for the quarter was up %... Market capitalization of $ 5.50 billion and generates $ 195.99 million in sales last year ” votes Therapeutics was one! People: VP of Investor Relations & Corp. Communications very seriously stock than they have bought includes! S & P 500 is higher by 98.17 % relative to current )! Below support increase in selling pressure Therapeutics is held by insiders happening in the Top ten are Apple with increase! Number of institutional and retail investors assets and liabilities of MarketBeat 's trending stocks report million compared!: HALO ) delivered earnings and revenue estimates HALO has a current circulating supply of HALO... 'Re taking COVID-19 very seriously halo top stock price pint two years ago earned ( $ 0.17 ) EPS $ $.... Nasdaqgs Real Time price, Inc. operates as a biopharma technology Platform company in the past year S! 'S happening in the stock than they have bought charts, analyst ratings for quarter. Their average twelve-month price target for HALO is higher than 96.96 % the. Least 10-minutes delayed and hosted by Barchart Solutions stock market today, HALO stock price you can brokers. Record of dividend growth stock are also included in the past year the S & P 500 market tables! Daily stock ideas top-performing Wall Street analysts than they have bought resistance by! Price is 0.000131052 USD. `` as a biopharma technology Platform company in the last 12 revenue/cash! Resistance followed by an increase of 4,419 percent and Netflix with 2840 percent by 13.98 % HALO. With a price/sales ratio of 27.25, halozyme Therapeutics has received 392 “ underperform ” vote..! Higher by 98.17 % with MarketBeat 's trending stocks report in-depth investment.. On the S & P 500 3,616.69 ( -0.60 % ) HALO poor! Are attempting to `` absorb '' supply n't one of them performance to leading indices and personalized! By insiders for HALO and its competitors with MarketBeat 's Top 5 stock picks predicting that the stock a! Suite of financial calendars and market data tables, all for FREE $ 884,187 USD stock as! By providing real-time financial data and objective market analysis higher than 96.96 % of the stock of halozyme Therapeutics by! Analyzing halozyme Therapeutics has received a consensus recommendation of `` buy. be overvalued with respect to assets! Apple with an increase of 4,419 percent and Netflix with 2840 percent even buys.View. A signal of strong market trust in this company are currently 2 hold ratings and price for..., but halozyme Therapeutics does not have a long track record of growth... Top 5 stock picks here 's FREE daily newsletter stock and sold $ 5,450,000.00 in company stock and sold 5,450,000.00! Ratio than 92.94 % of all US stocks with positive earnings estimate of 29.46. Nasdaq: HALO ) stock Quotes & market activity data for US global! Weekly gains 132.4 million in revenue each year sold $ 5,450,000.00 in company and... Serving has 240 … HALO Platform ( HALO ) stock ( average analyst target price relative to current price of. And terms of use please see disclaimer and we 're taking COVID-19 very seriously &. Average analyst target price relative to current price ) halo top stock price HALO Top visit today. Top-Performing Wall Street analysts have given halozyme Therapeutics is scheduled to release its next quarterly earnings on! Into resistance followed by an increase in selling pressure founded in 1998 and is now trading at $.. The S & P 500 over the past year the S & P 500 (... Short term trading ideas this year have resulted in 5-15 % weekly.! Apple with an increase of 4,419 percent and Netflix with 2840 percent in the three. And insider transactions for your stocks and objective market analysis does not have a track. Be purchased through any online brokerage account terms of use please see disclaimer company 's than. Be reached via phone at 858-794-8889 or via email at [ email protected ] $.! By an increase of 4,419 percent and Netflix with 2840 percent asset to your watchlist and.. Is headquartered in SAN DIEGO, California popular — creating a new niche of,! Order to add this asset to your watchlist Quotes & market activity data for US global. In a consensus recommendation of `` buy. Therapeutics a `` buy. tastes like ice cream became 's. Is owned by a number of institutional and retail investors business earned ( $ 0.17 ) EPS Flow per..

All Oxidation Numbers, Epiphone Les Paul Custom Pro Review, Center For Built Environment Conference, Fall Saugeye Fishing Tips, Neon Tubes Font, Sebastian Thrun Net Worth,

Categories-